Results 111 to 120 of about 16,084 (209)

Transvaginal Ultrasound for Endometriosis: Learning From a Decade of Diagnostic Challenges Through a Retrospective Observational Cohort Study

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 5, October 2026.
ABSTRACT Background Endometriosis is a chronic, inflammatory condition associated with pelvic pain, subfertility, and reduced quality of life. Advances in enhanced transvaginal ultrasound (eTVUS), including systematic compartment‐based scanning protocols and improved operator training, have increased diagnostic accuracy, particularly for deep ...
Candice Dry   +8 more
wiley   +1 more source

Bilateral papillary cystadenoma of the broad ligament: a manifestation of Von Hippel–Lindau disease: a case report

open access: yesJournal of Medical Case Reports
Background While papillary cystadenomas of the epididymis are relatively common, the occurrence of papillary cystadenomas in female individuals, particularly in the ovaries, remains exceedingly rare.
Haifa Bergaoui   +10 more
doaj   +1 more source

Digital health interventions for psychological and cognitive care in cancer patients and caregivers: A RE‐AIM‐based systematic review

open access: yesApplied Psychology: Health and Well-Being, Volume 18, Issue 5, October 2026.
Abstract Beyond physical challenges, cancer can cause psychological and cognitive challenges for patients, caregivers, and family members. Digital health interventions show promise in addressing these issues. However, evidence on their applicability in daily cancer care is limited. The objective of this systematic review is to evaluate the internal and
Melissa Heifez   +16 more
wiley   +1 more source

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort

open access: yesCancer Science, Volume 117, Issue 10, Page 2819-2826, October 2026.
Off‐label nivolumab treatment guided by CGP results was evaluated in 56 patients with advanced solid tumors. TMB‐High was the predominant biomarker leading to nivolumab treatment. Nivolumab showed limited clinical benefit in 50 patients with measurable disease, with an ORR of 16.0%, DCR of 40.0%, median PFS of 2.7 months, and median OS of 7.2 months ...
Masashi Kanai   +16 more
wiley   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

open access: yesAngewandte Chemie International Edition, Volume 65, Issue 39, 21 September 2026.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber   +4 more
wiley   +1 more source

The evolving role of immunotherapy in ovarian cancer

open access: yesCancer, Volume 132, Issue 18, 15 September 2026.
Abstract Ovarian cancer remains a major cause of gynecologic cancer mortality; and, although immune checkpoint inhibitors have transformed treatment in other solid tumors, their activity in ovarian cancer has been limited by tumor heterogeneity, an immunosuppressive tumor microenvironment, and the lack of robust predictive biomarkers.
Ana Carolina Veneziani   +2 more
wiley   +1 more source

Laparoscopic Management of Isolated Fallopian Tube Torsion in Pregnancy. [PDF]

open access: yesCRSLS
Joyce T   +4 more
europepmc   +1 more source

First documented case of cervical stenosis resulting in pyometra and fallopian tube torsion. [PDF]

open access: yesBMC Womens Health
Yigzaw KT   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy